FrancophonIA/ELRC3.0 huggingface dataset:
English: Bacterial resistance mechanisms that could potentially affect ceftazidime/avibactam include mutant or acquired PBPs, decreased outer membrane permeability to either compound, active efflux of either compound, and β-lactamase enzymes refractory to inhibition by avibactam and able to hydrolyse ceftazidime.
Croatian: Bakterijski mehanizmi rezistencije koji bi mogli utjecati na ceftazidim/avibaktam uključuju mutirane ili stečene PBP-ove, smanjenu propusnost vanjske membrane za bilo koju od dvije djelatne tvari, aktivni efluks bilo koje od dvije djelatne tvari te beta-laktamaze koje su refraktorne na inhibiciju avibaktamom i koje su sposobne hidrolizirati ceftazidim.
English: In two studies in patients with cIAI, the most common diagnosis (approximately 42%) was appendiceal perforation or peri-appendiceal abscess.
Croatian: U dva ispitivanja kod bolesnika s kompliciranim intraabdominalnim infekcijama, najčešća dijagnoza (otprilike 42%) bila je perforacija crvuljka ili apsces u tkivu oko crvuljka.
English: Zavicefta is an antibiotic medicine that contains two active substances ceftazidime and avibactam.
Croatian: Zavicefta je antibiotik koji sadrži dvije djelatne tvari - ceftazidim i avibaktam.
English: Clinical efficacy has not been established against the following pathogens that are relevant to the approved indications although in vitro studies suggest that they would be susceptible to ceftazidime/avibactam in the absence of acquired mechanisms of resistance.
Croatian: Klinička djelotvornost protiv sljedećih patogena relevantnih za odobrene indikacije nije ustanovljena, premda ispitivanja in vitro ukazuju na to da bi oni bili osjetljivi na ceftazidim/avibaktam u odsutnosti stečenih mehanizama rezistencije.
English: ceftazidime 2 g/avibactam 0.5 g
Croatian: ceftazidim 2 g/avibaktam 0,5 g
English: Do not use Zavicefta if:
Croatian: Nemojte primjenjivati lijek Zavicefta:
English: • yellowing of the whites of the eyes or skin sudden onset of a severe rash or blistering or peeling skin, possibly accompanied by a high fever or joint pain (these may be signs of more serious medical conditions such as toxic epidermal necrolysis, Stevens-Johnson syndrome, erythema multiforme or a condition known as DRESS,
Croatian: • iznenadan nastup teškog osipa, mjehurića na koži ili ljuštenja kože, koji mogu biti praćeni visokom vrućicom ili bolovima u zglobovima (to mogu biti znakovi ozbiljnijih stanja, poput toksične epidermalne nekrolize, Stevens-Johnsonova sindroma, multiformnog eritema ili stanja koje se naziva reakcija na lijek s eozinofilijom i sistemskim simptomima [DRESS])
English: • infections of the stomach and gut (abdomen)
Croatian: • infekcija u trbušnoj šupljini (abdomenu)
English: Approximate ceftazidime/avibactam concentration (mg/mL)
Croatian: Približna koncentracija ceftazidima/avibaktama (mg/ml)
English: If you have any further questions, ask your doctor or nurse.
Croatian: - Ako imate dodatnih pitanja, obratite se liječniku ili medicinskoj sestri.
English: The concentration time profiles are similar for ELF and plasma.
Croatian: Profil koncentracije tijekom vremena u tekućini epitelne ovojnice i u plazmi je sličan.
English: 20 mL glass vial (Type 1) closed with a rubber (halobutyl) stopper and aluminium seal with flip-off cap.
Croatian: Staklena bočica od 20 ml (staklo tipa 1), zatvorena gumenim (halobutil) čepom i aluminijskim prstenom s "flip-off" zatvaračem.
English: Dose recommendations are based on pharmacokinetic modelling Ceftazidime and avibactam are removed by haemodialysis (see sections 4.9 and 5.2).
Croatian: Preporuke za doziranje temelje se na farmakokinetičkom modeliranju Ceftazidim i avibaktam se uklanjaju hemodijalizom (vidjeti dijelove 4.9 i 5.2).
English: However, if you have side effects or think you have been given too much Zavicefta, tell your doctor or nurse straight away.
Croatian: Međutim, ako imate nuspojave ili mislite da ste primili preveliku dozu lijeka Zavicefta, odmah o tome obavijestite svog liječnika ili medicinsku sestru.
English: Vials of ceftazidime/avibactam powder should be reconstituted with 10 mL of sterile water for injections, followed by shaking until the content dissolves.
Croatian: Bočice s praškom ceftazidima/avibaktama treba rekonstituirati s 10 ml sterilne vode za injekcije, nakon čega bočicu treba tresti sve dok se njezin sadržaj ne otopi.
English: If you are not sure, talk to your doctor or nurse before using Zavicefta.
Croatian: Ako niste sigurni, obratite se svom liječniku ili medicinskoj sestri prije nego primite lijek Zavicefta.
English: • fungal infections, including those of the mouth and vagina
Croatian: • gljivične infekcije, uključujući infekcije usne šupljine i rodnice
English: Elimination of ceftazidime and avibactam is decreased in patients with moderate or severe renal impairment.
Croatian: Eliminacija ceftazidima i avibaktama smanjena je u bolesnika s umjerenim ili teškim oštećenjem bubrega.
English: In two studies in patients with cUTI, 381/1091 (34.9%) patients were enrolled with cUTI without pyelonephritis while 710 (65.1%) were enrolled with acute pyelonephritis (mMITT population).
Croatian: U dva ispitivanja kod bolesnika s kompliciranom infekcijom mokraćnog sustava, 381/1091 (34,9%) uključeni bolesnik s kompliciranom infekcijom mokraćnog sustava nije imao pijelonefritis dok je 710 (65,1%) uključenih bolesnika imalo akutni pijelonefritis (mMITT populacija).
English: Contains sodium carbonate - see package leaflet for further details.
Croatian: Sadrži natrijev karbonat - za dodatne informacije vidjeti uputu o lijeku.
English: In some patients, the creatinine clearance estimated from serum creatinine can change quickly, especially early in the course of treatment for the infection.
Croatian: U nekih bolesnika, osobito ranije tijekom liječenja infekcije, klirens kreatinina procijenjen na temelju serumskog kreatinina može se brzo promijeniti.
English: The terminal half-life (t½) of both ceftazidime and avibactam is about 2 h after intravenous administration.
Croatian: Terminalni poluvijek (t½) ceftazidima i avibaktama nakon intravenske primjene iznosi približno 2 sata.
English: Do not use Zavicefta if any of the above apply to you.
Croatian: Nemojte primiti lijek Zavicefta ako se nešto od navedenog odnosi na Vas.
English: A 100 mL infusion bag can be used to prepare the infusion, based on the patient's volume requirements.
Croatian: Za pripremu infuzije može se upotrijebiti infuzijska vrećica od 100 ml, sukladno volumenu koji je bolesniku potreban.
English: The contents of Zavicefta vial should be reconstituted with 10 mL of sterile water for injections.
Croatian: Sadržaj bočice lijeka Zavicefta treba rekonstituirati s 10 ml sterilne vode za injekcije.
English: Note: to preserve product sterility, it is important that the gas relief needle is not inserted through the vial closure before the product is dissolved.
Croatian: Napomena: da bi se očuvala sterilnost lijeka, važno je ne uvoditi iglu za odvod plina kroz čep bočice prije nego se lijek otopi.
English: What Zavicefta is and what it is used for
Croatian: Što je Zavicefta i za što se koristi
English: Other side effects Tell your doctor or nurse if you notice any of the following side effects:
Croatian: Ostale nuspojave Obavijestite svog liječnika ili medicinsku sestru ako primijetite bilo koju od sljedećih nuspojava:
English: Insert a gas relief needle through the vial closure to relieve the internal pressure.
Croatian: Uvedite iglu za odvod plina kroz čep bočice da biste smanjili tlak unutar bočice.
English: • The other ingredient is sodium carbonate (anhydrous).
Croatian: • Drugi sastojak je natrijev karbonat (bezvodni).
English: It is recommended that Zavicefta should be used to treat infections due to aerobic Gram-negative organisms in adult patients with limited treatment options only after consultation with a physician with appropriate experience in the management of infectious diseases (see section 4.4).
Croatian: Preporučuje se koristiti lijek Zavicefta za liječenje infekcija uzrokovanih aerobnim Gram-negativnim organizmima u odraslih bolesnika s ograničenim mogućnostima liječenja tek nakon savjetovanja s liječnikom koji ima odgovarajuće iskustvo u liječenju infektivnih bolesti (vidjeti dio 4.4).
English: Instructions for the reconstitution of Zavicefta vial are summarized below:
Croatian: Upute za rekonstituciju bočice lijeka Zavicefta sažeto su prikazane u nastavku:
English: Ceftazidime/avibactam use may cause development of a positive direct antiglobulin test (DAGT, or Coombs test), which may interfere with the cross-matching of blood and/or may cause drug induced immune haemolytic anaemia (see section 4.8).
Croatian: Primjena ceftazidima/avibaktama može dovesti do pozitivnog nalaza direktnog antiglobulinskog testa (DAGT ili Coombsov test), što može utjecati na križnu probu krvi i/ili uzrokovati imunu hemolitičku anemiju izazvanu primjenom lijeka (vidjeti dio 4.8).
English: The antimicrobial activity of ceftazidime against specific pathogens has been shown to best correlate with the percent time of free-drug concentration above the ceftazidime/avibactam minimum inhibitory concentration over the dose interval (%fT >MIC of ceftazidime/avibactam).
Croatian: Pokazalo se da antimikrobna aktivnost ceftazidima protiv specifičnih patogena najbolje korelira s postotkom vremena tijekom intervala doziranja u kojem je koncentracija nevezanog lijeka iznad minimalne inhibitorne koncentracije ceftazidima/avibaktama (%fT > MIK ceftazidima/avibaktama).
English: Both ceftazidime and avibactam penetrate into human bronchial epithelial lining fluid (ELF) to the same extent with concentrations around 30% of those in plasma.
Croatian: I ceftazidim i avibaktam prodiru u bronhalnu tekućinu epitelne ovojnice u ljudi u istoj mjeri u koncentracijama koje iznose približno 30% onih u plazmi.
English: Tell your doctor straight away if you notice any of the serious side effects above.
Croatian: Odmah obavijestite svog liječnika ako primijetite bilo koju od navedenih ozbiljnih nuspojava.
English: Marketing Authorisation Holder Pfizer Ireland Pharmaceuticals Operations Support Group Ringaskiddy, County Cork Ireland
Croatian: Nositelj odobrenja za stavljanje lijeka u promet Pfizer Ireland Pharmaceuticals Operations Support Group Ringaskiddy, County Cork Irska
English: Elderly No dosage adjustment is required in elderly patients (see section 5.2).
Croatian: Nije potrebno prilagođavati dozu u starijih bolesnika (vidjeti dio 5.2).
English: The use of ceftazidime/avibactam to treat patients with infections due to Gram-negative aerobic pathogens who have limited treatment options is based on experience with ceftazidime alone and on analyses of the pharmacokinetic-pharmacodynamic relationship for ceftazidime/avibactam (see section
Croatian: Primjena ceftazidima/avibaktama za liječenje bolesnika s infekcijama Gram-negativnim aerobnim patogenima a koji imaju ograničene mogućnosti liječenja temelji se na iskustvu primjene samo ceftazidima i analizi farmakokinetičkog-farmakodinamičkog odnosa za ceftazidim/avibaktam (vidjeti dio 5.1).
English: • an antibiotic called chloramphenicol
Croatian: • antibiotik koji se zove kloramfenikol
English: However, the possibility that haemolytic anaemia could occur in association with Zavicefta treatment cannot be ruled out.
Croatian: Međutim, ne može se isključiti mogućnost pojave hemolitičke anemije tijekom liječenja lijekom Zavicefta.
English: powder for concentrate for solution for infusion 10 vials
Croatian: prašak za koncentrat za otopinu za infuziju 10 bočica
English: Ceftazidime does not interfere with enzymebased tests for glycosuria.
Croatian: Ceftazidim ne utječe na enzimske testove za glikozuriju.
English: To be used in combination with metronidazole when anaerobic pathogens are known or suspected to be contributing to the infectious process To be used in combination with an antibacterial agent active against Gram-positive pathogens when these are known or suspected to be contributing to the infectious process The total duration shown may include intravenous Zavicefta followed by appropriate oral therapy There is very limited experience with the use of Zavicefta for more than 14 days
Croatian: Kada je potvrđeno ili se sumnja da Gram-pozitivni patogeni pridonose razvoju infekcije, primjenjivati u kombinaciji s antibakterijskim lijekovima koji djeluju na Gram-pozitivne organizme Prikazano ukupno trajanje može uključivati intravensku primjenu lijeka Zavicefta nakon koje slijedi odgovarajuća oralna terapija Iskustvo s primjenom lijeka Zavicefta dulje od 14 dana je vrlo ograničeno
English: Infusion time
Croatian: Trajanje infuzije
English: What Zavicefta contains
Croatian: Što Zavicefta sadrži
English: Carcinogenicity studies have not been conducted with avibactam.
Croatian: Nisu provedena ispitivanja kancerogenosti avibaktama.
English: It is given as a drip into a vein - this will take about 2 hours.
Croatian: Primjenjuje se ukapavanjem (dripom) u venu tijekom približno 2 sata.
English: Avibactam does not inhibit class B enzymes (metallo-β-lactamases) and is not able to inhibit many class D enzymes.
Croatian: Avibaktam ne inhibira enzime klase B (metalo- beta-laktamaze) i ne može inhibirati mnoge enzime klase D.
English: Zavicefta should not be mixed with or physically added to solutions containing other medicinal products.
Croatian: Zavicefta se ne smije miješati s otopinama koje sadrže druge lijekove niti fizički dodavati u njih.
English: Hypersensitivity to any cephalosporin antibacterial agent.
Croatian: Preosjetljivost na bilo koji drugi cefalosporinski antibakterijski lijek.
English: As ceftazidime and avibactam do not appear to undergo significant hepatic metabolism, the systemic clearance of either active substance is not expected to be significantly altered by hepatic impairment.
Croatian: Budući da ceftazidim i avibaktam naizgled nisu podvrgnuti značajanom metabolizmu u jetri, ne očekuje se da će oštećenje jetre značajno utjecati na sistemski klirens bilo koje od dvije djelatne tvari.
English: Direct antiglobulin test (DAGT or Coombs test) seroconversion and potential risk of haemolytic anaemia
Croatian: Serokonverzija dokazana direktnim antiglobulinskim testom (DAGT ili Coombsov test) i mogući rizik od hemolitičke anemije
English: Avibactam and ceftazidime do not inhibit the major renal or hepatic transporters in the clinically relevant exposure range, therefore the interaction potential via these mechanisms is considered to be low.
Croatian: Budući da avibaktam i ceftazidim ne inhibiraju glavne bubrežne ni jetrene prijenosnike unutar klinički značajnog raspona izloženosti, smatra se da je mogućnost interakcije putem tih mehanizama mala.
English: The inhibitory spectrum of avibactam includes many of the enzymes that inactivate ceftazidime, including Ambler class A β-lactamases and class C β-lactamases.
Croatian: Inhibitorni spektar avibaktama obuhvaća mnoge enzime koji inaktiviraju ceftazidim, uključujući beta-laktamaze Ambler klase A i beta-laktamaze klase C.
English: This diagnosis should be considered in patients who present with diarrhoea during or subsequent to the administration of Zavicefta (see section 4.8).
Croatian: Tu je dijagnozu potrebno razmotriti u bolesnika u kojih se tijekom ili nakon primjene lijeka Zavicefta pojavi proljev (vidjeti dio 4.8).
English: Adverse reactions are classified according to frequency and System Organ Class.
Croatian: Nuspojave su razvrstane prema učestalosti i klasifikaciji organskih sustava.
English: Mild to moderate hepatic impairment had no effect on the pharmacokinetics of ceftazidime in individuals administered 2 g intravenously every 8 hours for 5 days, provided renal function was not impaired.
Croatian: Blago do umjereno oštećenje jetre nije utjecalo na farmakokinetiku ceftazidima u osoba u kojih je intravenski primijenjena doza od 2 g svakih 8 sati tijekom 5 dana, pod uvjetom da im bubrežna funkcija nije bila oštećena.
English: Animal studies with avibactam do not indicate harmful effects with respect to fertility (see section 5.3).
Croatian: Ispitivanja avibaktama na životinjama ne ukazuju na štetan učinak na plodnost (vidjeti dio 5.3).
English: Nausea and diarrhoea were usually mild or moderate in intensity.
Croatian: Mučnina i proljev su obično bile blage do umjerene težine.
English: The colour of Zavicefta infusion solution is pale yellow and free of particles.
Croatian: Otopina lijeka Zavicefta za infuziju je blijedo žute boje i ne sadrži čestice.
English: Talk to your doctor or nurse before using Zavicefta if:
Croatian: Obratite se svom liječniku ili medicinskoj sestri prije nego primite lijek Zavicefta:
English: The effects of ceftazidime/avibactam on fertility in humans have not been studied.
Croatian: Nisu ispitivani učinci ceftazidima/avibaktama na plodnost ljudi.
English: Zavicefta is also indicated for the treatment of infections due to aerobic Gram-negative organisms in adult patients with limited treatment options (see sections 4.2, 4.4 and 5.1).
Croatian: Zavicefta je također indicirana za liječenje infekcija uzrokovanih aerobnim Gram-negativnim organizmima u odraslih bolesnika s ograničenim mogućnostima liječenja (vidjeti dijelove 4.2, 4.4 i
English: Overdose with ceftazidime/avibactam can lead to neurological sequelae including encephalopathy, convulsions and coma, due to the ceftazidime component.
Croatian: Predoziranje ceftazidimom/avibaktamom može dovesti do neuroloških posljedica uključujući encefalopatiju, konvulzije i komu, i to zbog ceftazidimske sastavnice.
English: Avibactam is a non β-lactam, βlactamase inhibitor that acts by forming a covalent adduct with the enzyme that is stable to hydrolysis.
Croatian: Avibaktam je nebetalaktamski inhibitor beta-laktamaze, koji djeluje tako da s tim enzimom stvara kovalentni spoj koji je stabilan na hidrolizu.
English: Following a single intravenous administration of 500 mg avibactam as a 30-minute IV infusion, the elderly had a slower terminal half-life of avibactam, which may be attributed to age related decrease in renal clearance.
Croatian: Nakon jednokratne intravenske primjene avibaktama u dozi od 500 mg u obliku 30-minutne i.v. infuzije, u starijih je osoba terminalni poluvijek avibaktama bio dulji, što se može pripisati dobno uvjetovanom smanjenju bubrežnog klirensa.
English: A dose of 1000 mg/250 mg or 750 mg/187.5 mg is achieved with 6.0 mL or 4.5 mL aliquots, respectively.
Croatian: Doza od 1000 mg/250 mg postiže se alikvotom od 6,0 ml, a doza od 750 mg/187,5 mg alikvotom od 4,5 ml.
English: Since a clinical interaction study of avibactam and probenecid has not been conducted, co-administration of avibactam with probenecid is not recommended.
Croatian: Budući da nije provedeno kliničko ispitivanje interakcija između avibaktama i probenecida, ne preporučuje se njihova istodobna primjena.
English: What Zavicefta is used for
Croatian: Za što se Zavicefta koristi
English: Hospital-acquired pneumonia, including ventilator-associated pneumonia In a single study in patients with nosocomial pneumonia 280/808 (34.7%) had VAP and 40/808 (5.0%) were bacteraemic at baseline.
Croatian: U jednom ispitivanju kod bolesnika sa nozokomijalnom pneumonijom, 280/808 (34,7%) imalo je pneumoniju povezanu s mehaničkom ventilacijom i 40/808 (5,0%) imalo je bakterijemiju na početku ispitivanja.
English: There is a small possibility that you may get a different infection caused by another bacteria during or after treatment with Zavicefta.
Croatian: Postoji mala mogućnost da tijekom ili nakon liječenja lijekom Zavicefta dobijete drugu infekciju koju uzrokuje neka druga bakterija.
English: The pharmacokinetics of ceftazidime in patients with severe hepatic impairment has not been established.
Croatian: Farmakokinetika ceftazidima u bolesnika s teškim oštećenjem jetre nije ustanovljena.
English: Among a subgroup with baseline CrCL 30 to 50 mL/min death occurred in 16.7% (9/54) of patients who received Zavicefta and metronidazole and 6.8% (4/59) of patients who received meropenem.
Croatian: U podskupini s vrijednosti CrCl na početku od 30 do 50 ml/min, smrt je nastupila u 16,7% (9/54) bolesnika koji su primali lijek Zavicefta i metronidazol te u 6,8% (4/59) bolesnika koji su primali meropenem.
English: Parenteral medicinal products should be inspected visually for particulate matter prior to administration.
Croatian: Lijekove za parenteralnu primjenu treba prije primjene vizualno pregledati kako bi se utvrdilo sadrže li čestice.
English: Zavicefta can also affect the results of some urine tests for sugar.
Croatian: Zavicefta može utjecati i na nalaze nekih pretraga mokraće kojima se određuje količina šećera.
English: Talk to your doctor before using Zavicefta if you are taking any of the following medicines:
Croatian: Prije primjene lijeka Zavicefta recite svom liječniku ako uzimate bilo koji od sljedećih lijekova:
English: • abnormal result with a test called “DAGT” or “Coombs”.
Croatian: • odstupanja u nalazima pretrage koja se zove "DAGT" ili "Coombsov test".
English: This test looks for antibodies that fight against your red blood cells.
Croatian: Tom se pretragom utvrđuje prisutnost protutijela koja napadaju crvene krvne stanice.
English: Controlled sodium diet
Croatian: Dijeta s kontroliranim unosom natrija
English: Infections due to aerobic Gram-negative organisms in patients with limited treatment options
Croatian: Gram-negativnim organizmima u bolesnika s ograničenim mogućnostima liječenja
English: (CYPRUS BRANCH) Τηλ: +357 22 817690
Croatian: Pfizer ΕΛΛΑΣ Α.Ε. (CYPRUS BRANCH) Τηλ: +357 22 817690
English: Very common: (may affect more than 1 in 10 people)
Croatian: Vrlo često: (mogu se javiti u više od 1 na 10 osoba)
English: Interference with laboratory tests
Croatian: Utjecaj na laboratorijske pretrage
English: Carcinogenicity studies have not been conducted with ceftazidime.
Croatian: Nisu provedena ispitivanja kancerogenosti ceftazidima.
English: MINIMUM PARTICULARS TO APPEAR ON SMALL IMMEDIATE PACKAGING UNITS
Croatian: PODACI KOJE MORA NAJMANJE SADRŽAVATI MALO UNUTARNJE PAKIRANJE
English: In pregnant rabbits administered avibactam at 300 and 1000 mg/kg/day, there was a dose-related lower mean foetal weight and delayed ossification, potentially related to maternal toxicity.
Croatian: Kod skotnih ženki kunića kojima je primijenjen avibaktam u dozama od 300 i 1000 mg/kg/dan primijećeno je o dozi ovisno smanjenje srednje vrijednosti tjelesne težine fetusa i usporeno okoštavanje, što bi moglo biti povezano s toksičnošću u majke.
English: Chloramphenicol is antagonistic in vitro with ceftazidime and other cephalosporins.
Croatian: Kloramfenikol ostvaruje antagonističko djelovanje in vitro kada se primjenjuje s ceftazidimom ili drugim cefalosporinima.
English: Gender and race The pharmacokinetics of ceftazidime/avibactam is not significantly affected by gender or race.
Croatian: Spol i rasa Spol i rasa ne utječu značajno na farmakokinetiku ceftazidima/avibaktama.
English: • increase in the amount of some enzymes produced by your liver - shown in blood tests
Croatian: • povećana količina nekih enzima koje proizvodi jetra - vidi se u nalazima krvnih pretraga
English: If any of the above apply to you (or you are not sure), talk to your doctor or nurse before using Zavicefta.
Croatian: Ako se nešto od navedenog odnosi na Vas (ili niste sigurni), obratite se svom liječniku ili medicinskoj sestri prije nego primite lijek Zavicefta.
English: Caution should be used if ceftazidime/avibactam is given to patients with a history of non-severe hypersensitivity to penicillins, monobactams or carbapenems.
Croatian: Potreban je oprez kada se ceftazidim/avibaktam primjenjuje u bolesnika koji u anamnezi imaju reakcije preosjetljivosti na peniciline, monobaktame ili karbapeneme koje nisu bile teške.
English: Dilute before use
Croatian: Za intravensku primjenu Razrijediti prije uporabe
English: Minimum Inhibitory Concentration (MIC) breakpoints established by the European Committee on Antimicrobial Susceptibility Testing (EUCAST) for ceftazidime/avibactam are as follows: Organisms
Croatian: European Committee on Antimicrobial Susceptibility Testing, EUCAST) su sljedeće: Organizmi
English: If you have any further questions on the use of this medicine, ask your doctor or nurse.
Croatian: U slučaju bilo kakvih pitanja u vezi s primjenom ovog lijeka, obratite se liječniku ili medicinskoj sestri.